This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Chung-Hong Hu, MD; A. Christine Miller, MD; Robert Peppercorn, MD; Eugene M. Farber, MD

Arch Dermatol. 1985;121(10):1326-1327.

Abstract
• An 80-year-old man who had had plaque-type psoriasis for 40 years experienced a rapid onset of generalized pustular psoriasis three days after initiation of propranolol hydrochloride therapy. Trial therapy with propranolol on two occasions resulted in similar episodes. The skin lesions and systemic symptoms resolved after the discontinuation of propranolol therapy and administration of methotrexate sodium. This case study documents propranolol—a β-blocker—as another causal factor for pustular psoriasis.

(Arch Dermatol 1985;121:1326-1327)

Author Affiliations
From the Department of Dermatology, Stanford (Calif) School of Medicine.

Footnotes
Accepted for publication Feb 5, 1985.

Reprint requests to Department of Dermatology, Room R-132, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305 (Dr Hu).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Beta-Blocker-Induced Psoriasis: A Rare Side Effect: A Case Report
Birhan Yilmaz et al.
ANGIOLOGY 2002;53:737-739.
ABSTRACT  

Atenolol-Induced Pustular Psoriasis
Wakefield et al.
Arch Dermatol 1990;126:968-969.
ABSTRACT